#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Piriformis syndrome Glomerulonephritis Infantile apnoea Hepatitis D Candida infection Heritable pulmonary arterial hypertension Arteriosclerosis Glioblastoma Anal cancer recurrent Brain stem glioma Systemic lupus erythematosus Head and neck cancer Diabetes insipidus Palmar-plantar erythrodysaesthesia syndrome X-linked lymphoproliferative syndrome More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Basic Information Hepatoblastoma – Basic Information Langerhans cell sarcoma – Basic Information Breast angiosarcoma metastatic – Treatment Leukoencephalopathy – Treatment Burkitt’s lymphoma Urea cycle disorder – Basic Information Brain stem glioma – Life with Disease Nephroblastoma – Life with Disease Waldenstrom’s macroglobulinaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paliperidone Fostemsavir Trometamol Dactinomycin Disitamab Vedotin Sufentanil Citrate Cart45Ra-Nkg2D Cells AUROCELL-TX Ly4100511 Formoterol Fumarate Dihydrate Icatibant VX-407 ZOLPIDEM TARTRATE Rbp030.2 Vx-522 Motixafortide L-Tyrosine Deupirfenidone Topotecan Hydrochloride GSKVX000000070248 Ferumoxytol More therapies…

    Learn about Your Condition

    Hepatic neoplasm Vitamin D deficiency Inflammation Eclampsia Magnetic resonance imaging Actinic keratosis Papulopustular rosacea Urinary incontinence Choroidal neovascularisation HER2 positive breast cancer Exudative retinopathy Adenocarcinoma pancreas Growth hormone deficiency Thymic carcinoma Head and neck cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

IgA nephropathy

  • Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Hydrochlorothiazide
    • Losartan Potassium
    • Ramipril
    Italy

  • Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Iptacopan
    Belgium Czechia Denmark France Germany Hungary +6

  • Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Irbesartan
    • Sparsentan
    • Dapagliflozin
    Belgium Croatia Czechia Estonia France Germany +5

  • Study of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    • IgA nephropathy
    Investigated Drugs:
    • Ravulizumab
    France Germany Italy The Netherlands Poland Spain +1

  • Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1
    Investigated Diseases:
    • Lupus nephritis
    • IgA nephropathy
    Investigated Drugs:
    • Vemircopan
    Germany Italy Spain

  • Study on the Effectiveness and Safety of Ravulizumab for Adults with Corticosteroid-Resistant IgA Nephropathy Flares

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Ravulizumab
    Spain
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!